1. Allogeneic hematopoietic stem cell transplantation for the treatment of patients with refractory mycosis fungoides/Sezary syndrome: a single center experience. (2019) Authors: Papadavid, E.; Pappa, V.; Nikolaou, V.; Hliakis, T.; Gkirkas, K.; Stamouli, M.; Karagiannidi, A.; Thomopoulos, T.; Theodoropoulos, K.; Tsirigotis, P. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Augmented apoptotic efficacy of brentuximab vedotin combined with lenalidomide in CD-30 expressing Sézary syndrome cell lines. (2019) Authors: Bakou, V.; Spathis, Aris; Bouhla, Anthi; Glezou, Eirini; Stavroulaki, Georgia; Thomopoulos, T.; Gkontopoulos, Konstantinos; Pappa, V.; Papadavid, E. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Laparoscopic segment V and VI resection with pedicular lymph nodes dissection for intrahepatic cholangiocarcinoma. (2021) Authors: Melloul, E.; Thomopoulos, T.; Demartines, N. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S991 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL. (23rd June 2022) Authors: Thomopoulos, T.; Bouchla, A.; Antoniadou, A.; Terpos, E.; Politou, M.; Stamoulis, K.; Koromboki, E.; Papageorgiou, S.; Kotanidou, A.; Kalomenidis, I.; Jahaj, E.; Grigoropoulou, S.; Pagoni, M.; Grouzi, E.; Poulakou, G.; Trontzas, I.; Labropoulou, S.; Mentis, A.; Bamias, A.; Tsiodras, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PB1917: PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF ELEMENTS OF THE ADAPTIVE IMMUNITY IN THE MICROENVIRONMENT OF MYELODYSPLASTIC SYNDROMES TREATED WITH 5-AZACITIDINE. (23rd June 2022) Authors: Tsakiraki, Z.; Papageorgiou, S.; Spathis, A.; Pouliakis, A.; Bouchla, A.; Thomopoulos, T.; Panayiotides, I. G.; Pappa, V.; Foukas, P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1796 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Topic: AS08-Treatment/AS08b-Current treatment options – Lower risk MDS: LUSPATERCEPT IN THE TREATMENT OF MDS PATIENTS. A SINGLE CENTER EXPERIENCE. (May 2023) Authors: Bouchla, A.; Thomopoulos, T.; Loucari, C.; Apostolopoulou, C.; Vryttia, P.; Zorba, A.; Gkondopoulos, K.; Papageorgiou, S.; Pappa, V. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Totally laparoscopic treatment of vaginal cuff dehiscence: A case report and systematic literature review. (2016) Authors: Thomopoulos, T.; Zufferey, G. Journal: International journal of surgery case reports Issue: Volume 25(2016) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗